- Corporate Officers - L
- Lyons Gary A
Insider Trading History of Lyons Gary A
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Lyons Gary A since 2005.
This trader's CIK number is 1123343.
At the time of last reporting, Lyons Gary A was the Director of Neurocrine Biosciences Inc. (stock ticker symbol NBIX).
Also see all insider trading activities at Neurocrine Biosciences Inc.
Note that in the past
LYONS GARY A also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Fresh Tracks Therapeutics, Inc. (BBI) by Lyons Gary A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | BBI | 0 | $0 | 0 | $0 | 8,333 | $0 |
| 2016 | BBI | 7,078 | $31,086 | 7,078 | $16,251 | 0 | $0 |
| 2013 | BBI | 5,953 | $59 | 0 | $0 | 0 | $0 |
| 2012 | BBI | 7,328 | $73 | 0 | $0 | 0 | $0 |
| 2011 | BBI | 18,750 | $187 | 0 | $0 | 0 | $0 |
| 2010 | BBI | 18,750 | $187 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Travere Therapeutics, Inc. (TVTX) by Lyons Gary A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | TVTX | 0 | $0 | 40,000 | $590,040 | 40,000 | $419,200 |
Yearly summary of insider trading at Neurocrine Biosciences Inc (NBIX) by Lyons Gary A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | NBIX | 0 | $0 | 0 | $0 | 1,435 | $0 |
| 2024 | NBIX | 0 | $0 | 25,000 | $3,575,356 | 27,100 | $1,068,999 |
| 2023 | NBIX | 0 | $0 | 25,000 | $3,009,710 | 15,000 | $194,700 |
| 2022 | NBIX | 0 | $0 | 35,000 | $3,665,510 | 30,000 | $290,550 |
| 2021 | NBIX | 0 | $0 | 17,000 | $1,768,081 | 0 | $0 |
| 2019 | NBIX | 0 | $0 | 20,000 | $1,971,795 | 0 | $0 |
| 2018 | NBIX | 0 | $0 | 40,000 | $4,043,484 | 15,000 | $105,750 |
| 2017 | NBIX | 0 | $0 | 10,000 | $729,180 | 15,000 | $51,000 |
| 2016 | NBIX | 0 | $0 | 0 | $0 | 15,000 | $46,050 |
| 2015 | NBIX | 0 | $0 | 45,000 | $2,068,350 | 15,000 | $71,400 |
| 2014 | NBIX | 0 | $0 | 20,000 | $313,200 | 85,000 | $933,300 |
| 2007 | NBIX | 0 | $0 | 0 | $0 | 63,091 | $465,296 |
| 2005 | NBIX | 0 | $0 | 55,000 | $2,910,710 | 0 | $0 |
Yearly summary of insider trading at Neorx Corp (PARD) by Lyons Gary A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2011 | PARD | 0 | $0 | 0 | $0 | 121,145 | $0 |
| 2010 | PARD | 0 | $0 | 0 | $0 | 85,000 | $0 |
Insider trading activities at 4 companies by Lyons Gary A:
1. Fresh Tracks Therapeutics, Inc. (BBI)
2. Travere Therapeutics, Inc. (TVTX)
3. Neurocrine Biosciences Inc (NBIX)
4. Neorx Corp (PARD)
Table 1. Insider trading of Fresh Tracks Therapeutics, Inc. (BBI) by Lyons Gary A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-08-31 | BBI | Option Ex | 692 | .00 | 0 |
| 2020-07-31 | BBI | Option Ex | 692 | .00 | 0 |
| 2020-06-30 | BBI | Option Ex | 691 | .00 | 0 |
| 2020-02-14 | BBI | Option Ex | 3,491 | .00 | 0 |
| 2020-05-31 | BBI | Option Ex | 692 | .00 | 0 |
| 2020-02-29 | BBI | Option Ex | 692 | .00 | 0 |
| 2020-03-31 | BBI | Option Ex | 691 | .00 | 0 |
| 2020-04-30 | BBI | Option Ex | 692 | .00 | 0 |
| 2016-12-05 | VICL | Sale | 7,078 | 2.30 | 16,251 |
| 2016-06-03 | VICL | Buy | 7,078 | 4.39 | 31,086 |
| 2013-05-23 | VICL | Buy | 5,953 | .01 | 59 |
| 2012-05-24 | VICL | Buy | 7,328 | .01 | 73 |
| 2011-05-26 | VICL | Buy | 18,750 | .01 | 187 |
| 2010-05-25 | VICL | Buy | 18,750 | .01 | 187 |
Table 2. Insider trading of Travere Therapeutics, Inc. (TVTX) by Lyons Gary A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-10-04 | TVTX | Option Ex | 40,000 | 10.48 | 419,200 |
| 2024-10-04 | TVTX | Sale | 40,000 | 14.75 | 590,040 |
Table 3. Insider trading of Neurocrine Biosciences Inc (NBIX) by Lyons Gary A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-05-22 | NBIX | Option Ex | 1,435 | .00 | 0 |
| 2024-08-13 | NBIX | Option Ex | 11,570 | 42.76 | 494,733 |
| 2024-08-13 | NBIX | Sale | 11,570 | 150.43 | 1,740,451 |
| 2024-07-16 | NBIX | Option Ex | 930 | 42.76 | 39,766 |
| 2024-07-16 | NBIX | Sale | 930 | 150.03 | 139,530 |
| 2024-05-17 | NBIX | Option Ex | 2,100 | .00 | 0 |
| 2024-05-14 | NBIX | Sale | 12,500 | 135.63 | 1,695,375 |
| 2024-05-14 | NBIX | Option Ex | 12,500 | 42.76 | 534,500 |
| 2023-12-22 | NBIX | Sale | 10,000 | 130.04 | 1,300,440 |
| 2023-12-01 | NBIX | Option Ex | 5,000 | 12.98 | 64,900 |
| 2023-12-01 | NBIX | Sale | 5,000 | 116.77 | 583,835 |
| 2023-09-12 | NBIX | Option Ex | 5,000 | 12.98 | 64,900 |
| 2023-09-12 | NBIX | Sale | 5,000 | 115.02 | 575,120 |
| 2023-09-01 | NBIX | Option Ex | 5,000 | 12.98 | 64,900 |
| 2023-09-01 | NBIX | Sale | 5,000 | 110.06 | 550,315 |
| 2022-10-31 | NBIX | Option Ex | 15,000 | 12.71 | 190,650 |
| 2022-10-31 | NBIX | Sale | 15,000 | 114.76 | 1,721,400 |
| 2022-10-04 | NBIX | Sale | 5,000 | 110.54 | 552,710 |
| 2022-04-25 | NBIX | Option Ex | 15,000 | 6.66 | 99,900 |
| 2022-04-25 | NBIX | Sale | 15,000 | 92.76 | 1,391,400 |
| 2021-10-07 | NBIX | Sale | 5,000 | 105.06 | 525,295 |
| 2021-06-10 | NBIX | Sale | 10,000 | 100.27 | 1,002,740 |
| 2021-01-25 | NBIX | Sale | 1,600 | 120.03 | 192,046 |
| 2021-01-26 | NBIX | Sale | 400 | 120.00 | 48,000 |
| 2019-11-08 | NBIX | Sale | 5,000 | 110.00 | 550,000 |
| 2019-11-01 | NBIX | Sale | 5,000 | 100.22 | 501,105 |
| 2019-07-30 | NBIX | Sale | 10,000 | 92.07 | 920,690 |
| 2018-11-02 | NBIX | Sale | 15,000 | 114.41 | 1,716,210 |
| 2018-06-13 | NBIX | Sale | 15,000 | 99.24 | 1,488,555 |
| 2018-04-03 | NBIX | Option Ex | 15,000 | 7.05 | 105,750 |
| 2018-02-15 | NBIX | Sale | 5,000 | 84.67 | 423,340 |
| 2018-02-05 | NBIX | Sale | 5,000 | 83.08 | 415,379 |
| 2017-12-01 | NBIX | Sale | 10,000 | 72.92 | 729,180 |
| 2017-02-14 | NBIX | Option Ex | 15,000 | 3.40 | 51,000 |
| 2016-05-06 | NBIX | Option Ex | 15,000 | 3.07 | 46,050 |
| 2015-09-18 | NBIX | Sale | 15,000 | 54.83 | 822,450 |
| 2015-03-24 | NBIX | Sale | 30,000 | 41.53 | 1,245,900 |
| 2015-02-10 | NBIX | Option Ex | 7,500 | 4.76 | 35,700 |
| 2015-01-20 | NBIX | Option Ex | 7,500 | 4.76 | 35,700 |
| 2014-09-15 | NBIX | Sale | 20,000 | 15.66 | 313,200 |
| 2014-03-07 | NBIX | Option Ex | 85,000 | 10.98 | 933,300 |
| 2007-04-23 | NBIX | Option Ex | 63,091 | 7.38 | 465,296 |
| 2005-12-05 | NBIX | Sale | 5,000 | 61.94 | 309,700 |
| 2005-11-22 | NBIX | Sale | 5,000 | 61.77 | 308,840 |
| 2005-11-18 | NBIX | Sale | 5,000 | 59.71 | 298,550 |
| 2005-11-03 | NBIX | Sale | 10,000 | 55.64 | 556,370 |
| 2005-10-28 | NBIX | Sale | 10,000 | 51.50 | 515,000 |
| 2005-09-07 | NBIX | Sale | 10,000 | 49.00 | 490,000 |
| 2005-08-18 | NBIX | Sale | 5,000 | 46.75 | 233,750 |
| 2005-06-15 | NBIX | Sale | 5,000 | 39.70 | 198,500 |
Table 4. Insider trading of Neorx Corp (PARD) by Lyons Gary A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2011-07-11 | PARD | Option Ex | 85,000 | .00 | 0 |
| 2011-06-09 | PARD | Option Ex | 36,145 | .00 | 0 |
| 2010-07-12 | PARD | Option Ex | 85,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Lyons Gary A
(Director of Neurocrine Biosciences Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.